Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,608,168 papers from all fields of science
Search
Sign In
Create Free Account
ZD 0473
Known as:
ZD-0473
, ZD0473
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Picoplatin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Preclinical Perspectives on Platinum Resistance
L. Kèlland
Drugs
2012
Corpus ID: 19582491
In the 30 years since the introduction of cisplatin into the clinic, laboratory studies have provided considerable information as…
Expand
Review
2012
Review
2012
New Developments and Approaches in the Platinum Arena
I. Judson
,
L. Kèlland
Drugs
2012
Corpus ID: 25305006
Following the introduction of cisplatin and the demonstration of its importance in the treatment of testicular and ovarian cancer…
Expand
Highly Cited
2005
Highly Cited
2005
The prediction of Raman spectra of platinum(II) anticancer drugs by density functional theory
D. Michalska
,
R. Wysokiński
2005
Corpus ID: 16740910
Highly Cited
2005
Highly Cited
2005
Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
H. Cheng
,
F. Huq
,
P. Beale
,
K. Fisher
European journal of medicinal chemistry
2005
Corpus ID: 94817
Review
2003
Review
2003
Toxicity of platinum compounds
J. Hartmann
,
H. Lipp
Expert opinion on pharmacotherapy
2003
Corpus ID: 24693109
Since the introduction of platinum-based combination chemotherapy, particularly cisplatin, the outcome of the treatment of many…
Expand
Review
2002
Review
2002
Platinum drugs in the treatment of non-small-cell lung cancer
J. Cosaert
,
E. Quoix
British Journal of Cancer
2002
Corpus ID: 17444962
The use of chemotherapy is considered standard therapy in patients with locally advanced non-small-cell lung cancer that cannot…
Expand
Review
2001
Review
2001
Current and future potential roles of the platinum drugs in the treatment of ovarian cancer.
M. Piccart
,
H. Lamb
,
J. Vermorken
Annals of oncology : official journal of the…
2001
Corpus ID: 17667381
The discovery of cisplatin more than two decades ago was the most important therapeutic advance in the treatment of ovarian…
Expand
Highly Cited
2000
Highly Cited
2000
Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.
K. Pestell
,
S. Hobbs
,
J. Titley
,
L. Kèlland
,
M. Walton
Molecular pharmacology
2000
Corpus ID: 20322078
Wild-type p53 is frequently mutated in late-stage ovarian cancer and has been proposed as a determinant of cisplatin…
Expand
Highly Cited
2000
Highly Cited
2000
Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines.
J. Holford
,
P. Beale
,
F. Boxall
,
S. Sharp
,
L. Kèlland
European journal of cancer
2000
Corpus ID: 22787685
Review
1999
Review
1999
Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
L. Kèlland
,
S. Sharp
,
C. O'Neill
,
F. Raynaud
,
P. Beale
,
I. Judson
Journal of inorganic biochemistry
1999
Corpus ID: 9884440
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE